EBV LMP2A provides a surrogate pre-B cell receptor signal through constitutive activation of the ERK/MAPK pathway

Journal of General Virology

Volumn 89, Issue 7, 2008, Pages 1563-1568

  Anderson, Leah J ^a   Longnecker, Richard ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; INTERLEUKIN 7; LATENT MEMBRANE PROTEIN 2; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; EBV ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN BARR VIRUS; EBV-ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN-BARR VIRUS; MATRIX PROTEIN; ONCOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PRE B CELL RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL GROWTH; CELL MATURATION; CELL PROLIFERATION; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; VIRUS ACTIVATION; WILD TYPE; ANIMAL; BIOSYNTHESIS; GENETICS; METABOLISM; PHOSPHORYLATION; VIROLOGY;

HUMAN HERPESVIRUS 4; MUS;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; B-LYMPHOCYTES; CELL PROLIFERATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; INTERLEUKIN-7; MICE; MICE, TRANSGENIC; ONCOGENE PROTEIN V-AKT; PHOSPHORYLATION; PRE-B CELL RECEPTORS; VIRAL MATRIX PROTEINS;

EID: 48849094262     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.2008/001461-0     Document Type: Article

References (47)

1. Bannish, G., Fuentes-Panana, E. M., Cambier, J. C., Pear, W. S. & Monroe, J. G. (2001). Ligand-independent signaling functions for the B lymphocyte antigen receptor and their role in positive selection during B lymphopoiesis. J Exp Med 194, 1583-1596.
2. Bell, A. I., Groves, K., Kelly, G. L., Croom-Carter, D., Hui, E., Chan, A. T. & Rickinson, A. B. (2006). Analysis of Epstein-Barr virus latent gene expression in endemic Burkitt's lymphoma and nasopharyngeal carcinoma tumour cells by using quantitative real-time PCR assays. J Gen Virol 87, 2885-2890.
3. Burkhardt, A. L., Bolen, J. B., Kieff, E. & Longnecker, R. (1992). An Epstein-Barr virus transformation-associated membrane protein interacts, with src family tyrosine kinases. J Virol 66, 5161-5167.
4. Caldwell, R. G., Wilson, J. B., Anderson, S. J. & Longnecker, R. (1998). Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. Immunity 9, 405-411.
5. Caldwell, R. G., Brown, R. C. & Longnecker, R. (2000). Epstein-Barr virus LMP2A-induced B-cell survival in two unique classes of EmuLMP2A transgenic mice. J Virol 74, 1101-1113.
6. Chen, S. Y., Lu, J., Shih, Y. C. & Tsai, C. H. (2002). Epstein-Barr virus latent membrane protein 2A regulates c-Jun protein through extracellular signal-regulated kinase. J Virol 76, 9556-9561.
7. Corcoran, A. E., Smart F. M., Cowling, R. J., Crompton, T., Owen, M. J. & Venkitaraman, A. R. (1996). The interleukin-7 receptor alpha chain transmits distinct signals for proliferation and differentiation during B lymphopoiesis. EMBO J 15, 1924-1932.
8. Corfe, S. A., Gray, A. P. & Paige, C. J. (2007). Generation and characterization of stromal cell independent IL-7 dependent B cell lines. J Immunol Methods 325, 9-19.
9. Era, T., Ogawa, M., Nishikawa, S., Okamoto, M., Honjo, T., Akagi, K., Miyazaki, J. & Yamamura, K. (1991). Differentiation of growth signal requirement of B lymphocyte precursor is directed by expression of immunoglobulin. EMBO J 10, 337-342.
10. L transgene. Immunity 4, 291-299.
11. Fleming, H. E. & Paige, C. J. (2001). Pre-B cell receptor signaling mediates selective response to IL-7 at the pro-B to pre-B cell transition via an ERK/MAP kinase-dependent pathway. Immunity 15, 521-531.
12. Fleming, H. E. & Paige, C. J. (2002). Cooperation between IL-7 and the pre-B cell receptor: a key to B cell selection. Semin Immunol 14, 423-430.
13. Fruehling, S. & Longnecker, R. (1997). The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction. Virology 235, 241-251.
14. Fruehling, S., Lee, S. K., Herrold, R., Frech, B., Laux, G., Kremmer, E., Grasser, F. A. & Longnecker, R. (1996). Identification of latent membrane protein 2A (LMP2A) domains essential for the LMP2A dominant-negative effect on B-lymphocyte surface immunoglobulin signal transduction. J Virol 70, 6216-6226.
15. Fruehling, S., Swart, R., Dolwick K. M., Kremmer, E. & Longnecker, R. (1998). Tyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein-Barr virus latency. J Virol 72, 7796-7806.
16. Fuentes-Panana, E. M., Bannish, G., Shah, N. & Monroe, J. G. (2004). Basal lgα/lgβ signals trigger the coordinated initiation of pre-B cell antigen receptor-dependent processes. J Immunol 173, 1000-1011.
17. Fukuda, M. & Longnecker, R. (2005). Epstein-Barr virus (EBV) latent membrane protein 2A regulates B-cell receptor-induced apoptosis and EBV reactivation through tyrosine phosphorylation. J Virol 79, 8655-8660.
18. Hardy, R. R., Carmack, C. E., Shinton, S. A., Kemp, J. D. & Hayakawa, K. (1991). Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J Exp Med 173, 1213-1225.
19. Ikeda, M. & Longnecker, R. (2005). Pre-B-cell colony formation assay. Methods Mol Biol 292, 279-284.
20. Jacob, A., Cooney, D., Pradhan, M. & Coggeshall, K. M. (2002). Convergence of signaling pathways on the activation of ERK in B cells. J Biol Chem 277, 23420-23426.
21. Kieff, E. D. & Rickinson, A. B. (2007). Epstein-Barr virus and its replication. In Fields Virology, 5th edn, pp. 2603-2654. Edited by P. M. H. David, M. Knipe, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman & S. E. Straus Philadelphia. PA: Lippincott-Raven publishers.
22. Konishi, K., Maruo, S., Kato, H. & Takada, K. (2001). Role of Epstein-Barr virus-encoded latent membrane protein 2A on virus-induced immortalization and virus activation. J Gen Virol 82, 1451-1456.
23. Longnecker, R. (2000). Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence? Adv Cancer Res 79, 175-200.
24. Longnecker, R., Druker, B., Roberts, T. M. & Kieff, E. (1991). An Epstein-Barr virus protein associated with cell growth transformation interacts with a tyrosine kinase. J Virol 65, 3681-3692.
25. Lu, J., Lin, W. H., Chen, S. Y., Longnecker, R., Tsai, S. C., Chen, C. L. & Tsai, C. H. (2006). Syk tyrosine kinase mediates Epstein-Barr virus latent membrane protein 2A-induced cell migration in epithelial cells. J Biol Chem 281, 8806-8814.
26. Mancao, C. & Hammerschmidt, W. (2007). Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival. Blood 110, 3715-3721.
27. Marshall, A. J., Fleming, H. E., Wu, G. E. & Paige, C. J. (1998). Modulation of the IL-7 dose-response threshold during pro-B cell differentiation is dependent on pre-B cell receptor expression. J Immunol 161, 6038-6045.
28. Miller, C. L., Longnecker, R. & Kieff, E. (1993). Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes. J Virol 67, 3087-3094.
29. Miller, C. L., Lee, J. H., Kieff, E. & Longnecker, R. (1994). An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking. Proc Natl Acad Sci U S A 91, 772-776.
30. Miller, C. L., Burkhardt A. L., Lee, J. H., Stealey, B., Longnecker, R., Bolen, J. B. & Kieff, E. (1995). Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases. Immunity 2, 155-166.
31. Monroe, J. G. (206). ITAM-mediated tonic signalling through pre-BCR and BCR complexes. Nat Rev Immunol 6, 283-294.
32. Morrison, J. A., Klingelhutz, A. J. & Raab-Traub, N. (2003). Epstein-Barr virus latent membrane protein 2A activates β-catenin signaling in epithelial cells. J Virol 77, 12276-12284.
33. Panousis, C. G. & Rowe, D. T. (1997). Epstein-Barr virus latent membrane protein 2 associates with and is a substrate for mitogen-activated protein kinase. J Virol 71, 4752-4760.
34. Portis, T. & Longnecker, R. (2004). Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/Pl3K/Akt pathway. Oncogene 23, 8619-8628.
35. Portis, T., Dyck, P. & Longnecker, R. (2003). Epstein-Barr Virus (EBV) LMP2A induces alterations in gene transcription similar to those observed in Reed-Sternberg cells of Hodgkin lymphoma. Blood 102, 4166-4178.
36. Rechsteiner, M. P., Berger, C., Weber, M., Sigrist, J. A., Nadal, D. & Bernasconi, M. (2007). Silencing of latent membrane protein 2B reduces susceptibility to activation of lytic Epstein-Barr virus in Burkitt's lymphoma Akata cells. J Gen Virol 88, 1454-1459.
37. Rickinson, A. B. & Kieff, E. (2007). Epstein-Barr virus. In Fields Virology, 5th edn, pp. 2655-2700. Edited by P. M. H. David, M. Knipe, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman & S. E. Straus. Philadelphia, PA: Lippincott-Raven Publishers.
38. Scholle, F., Bendt, K. M. & Raab-Traub, N. (2000). Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt. J Virol 74, 10681-10689.
39. Shaffer, A. L. & Schlissel, M. S. (1997). A truncated heavy chain protein relieves the requirement for surrogate light chains in early B cell development. J Immunol 159, 1265-1275.
40. Steelman, L. S., Pohnert, S. C., Shelton, J. G., Franklin, R. A., Bertrand, F. E. & McCubrey, J. A. (2004). JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis. Leukemia 18, 189-218.
41. Swanson-Mungerson, M. A., Caldwell, R. G., Bultema, R. & Longnecker, R. (2005). Epstein-Barr virus LMP2A alters in vivo and in vitro models of B-cell anergy, but not deletion, in response to autoantigen. J Virol 79, 7355-7362.
42. Swanson-Mungerson, M., Bultema, R. & Longnecker, R. (2006). Epstein-Barr virus LMP2A enhances B-cell responses in vivo and in vitro. J Virol 80, 6764-6770.
43. Tao, O., Robertson, K. D., Manns, A., Hildesheim, A. & Ambinder, R. F. (1998). Epstein-Barr virus (EBV) in endemic Burkitt's lymphoma: molecular analysis of primary tumor tissue. Blood 91, 1373-1381.
44. Teh, Y. M. & Neuberger, M. S. (1997). The immunoglobulin (Ig)α and lgβ cytoplasmic domains are independently sufficient to signal B cell maturation and activation in transgenic mice. J Exp Med 185, 1753-1758.
45. Thorley-Lawson, D. A. (2005). EBV the prototypical human tumor virus-just how bad is it? J Allergy Clin Immunol 116, 251-261.
46. Thorley-Lawson, D. A. & Gross, A. (2004). Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 350, 1328-1337.
47. Xue, S. A., Labrecque, L. G., Lu, Q. L., Ong, S. K., Lampert, I. A., Kazembe, P., Molyneux, E., Broadhead, R. L., Borgstein, E. & Griffin, B. E. (2002). Promiscuous expression of Epstein-Barr virus genes in Burkitt's lymphoma from the central African country Malawi. Int J Cancer 99, 635-643.